HDAC9 and systemic lupus erythematosus: A recent study shows that HDAC inhibitors may be suitable for treatment of autoimmunity, while primary responses to the same inhibitors were greatly impaired, probably explaining the contradiction between the positive similarity score we obtained and the potential use of HDAC inhibitors in SLE [27].